Bak1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| BAK1 Protein | |
|---|---|
| Protein Name | BAK1 |
| Gene | BAK1 |
| UniProt ID | Q9Y2D5 |
| PDB ID | 1JBQ, 2IMT, 4U2V |
| Molecular Weight | 23 kDa |
| Subcellular Localization | Mitochondria (constitutively) |
| Protein Family | BCL2 family (BAX/BAK subgroup) |
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
BAK1 is a 23 kDa protein with BH1, BH2, and BH3 domains. Unlike BAX, BAK1 is constitutively localized to mitochondria. In its inactive state, BAK1 is held in check by anti-apoptotic proteins. Upon apoptotic signaling, BAK1 oligomerizes in the mitochondrial outer membrane to form large pores that facilitate MOMP.
BAK1 is a key executor of mitochondrial apoptosis:
| Disease | Role | Mechanism |
|---|---|---|
| Neurodegeneration | Pro-apoptotic | Neuronal death |
| Stroke | Pro-apoptotic | Ischemic injury |
The study of Bak1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.